| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.6 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |